Sanibel Captiva Trust Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Sanibel Captiva Trust Company’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.94M	Sell	4,719 -93	-2%	-$63.3K	0.07%	166
2026 Q1	$3.72M	Hold	4,812	–	–	0.1%	143
2025 Q4	$3.71M	Sell	4,812 -10	-0.2%	-$6.79K	0.1%	145
2025 Q3	$2.71M	Sell	4,822 -43	-0.9%	-$24.3K	0.08%	159
2025 Q2	$2.55M	Buy	4,865 +163	+3%	+$91K	0.08%	157
2025 Q1	$2.98M	Sell	4,702 -220	-4%	-$151K	0.1%	143
2024 Q4	$3.51M	Sell	4,922 -25	-0.5%	-$21K	0.11%	132
2024 Q3	$5.2M	Sell	4,947 -81	-2%	-$90.1K	0.17%	107
2024 Q2	$5.28M	Sell	5,028 -54	-1%	-$52.3K	0.18%	102
2024 Q1	$4.89M	Sell	5,082 -56	-1%	-$53.2K	0.17%	104
2023 Q4	$4.51M	Buy	+5,138	New	+$4.23M	0.17%	101

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sanibel Captiva Trust Company's REGN Position: Q2 2026 in Review

Sanibel Captiva Trust Company reduced its Regeneron Pharmaceuticals (REGN) stake by 1.9% in Q2 2026, selling an estimated $63.3K and leaving 4,719 shares worth $2.94M. The position accounts for 0.07% of the portfolio, ranked #166.

Sanibel Captiva Trust Company first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.28M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Sanibel Captiva Trust Company held 4,719 shares of Regeneron Pharmaceuticals worth $2.94M as of Q2 2026.
Sanibel Captiva Trust Company sold 93 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $63.3K.
Regeneron Pharmaceuticals made up 0.07% of Sanibel Captiva Trust Company's portfolio in Q2 2026, its #166 holding.
Sanibel Captiva Trust Company first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Sanibel Captiva Trust Company's Regeneron Pharmaceuticals position peaked at $5.28M in Q2 2024.
1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q2 2026, filed 27 Jul 2026.